Luca Incrocci is Professor of Genito-Urinary Radiotherapy and sexologist in the Department of Radiation Oncology at the Erasmus MC Cancer Institute, Rotterdam, The Netherlands. He received his M.D. in 1992 at the University of Pisa, Italy, and then joined the University Hospital Rotterdam to complete residencies in the Departments of Urology and Radiation Oncology. He is actively involved in the teaching and research of fellows and students. Prof. Incrocci is a member of several scientific societies including the European Association of Urology, the European and International Societies for Sexual Medicine. Prof. Incrocci is a manuscript reviewer for a number of international journals; he is Associate Editor of the European Journal of Sexual Health and is the Past-President of the International Society for Sexual Medicine. Prof. Incrocci is the author of more than 150 peer-reviewed papers, reviews, and book chapters and has co-edited the books: Handbook of Sexual and Gender Identity Disorder and Cancer and Sexual Function.

Dr. Wittmann is an Associate Professor Emerita of Urology and Adjunct Associate Professor of Social Work. She is a lead faculty in the Brandon Prostate Cancer Survivorship Program with clinical and research interest in sexual health and quality of life in cancer survivorship. She uses mixed methods to understand issues in cancer survivorship care and to evaluate interventions designed to improve patients' and partners' outcomes. She is faculty in the Mixed Methods Research Program at the University of Michigan. She is an Associate Editor of the Journal of Sexual Medicine.

Dr. Lawrence C. Jenkins received his MD from the University of Buffalo School of Medicine and Biomedical Sciences. He finished his urology training at the University of Miami and followed that with a fellowship in Male Sexual and Reproductive Medicine at Memorial Sloan-Kettering Cancer Center and the Center for Male Reproductive Medicine and Microsurgery at the Weill Medical College of Cornell University in New York, NY. Dr. Jenkins practices at the Tulane University Department of Urology, as an Associate Professor, where he focuses on male sexual and reproductive medicine.

Philip Odiyo Ouma is currently working as Patient Support Manager at Faraja Cancer Support Trust in Nairobi and Eldoret. His passion for Psycho-Oncology began 15 years ago. Besides having a Master’s degree in Counselling Psychology, he is currently studying for a research doctoral degree at Erasmus University (Netherlands). Philip’s was selected for a Clinical Observership and training at Memorial Sloan Kettering Cancer Centre in New York where he was mentored by Dr. Jimmie Holland under the Union for International Cancer Control Fellowship in 2014. Besides, his work at Faraja. Philip is also a fellow at the Association of Union for International Cancer Control Fellows and was awarded Naomi Stearns Fellow in 2018 for his role in developing psychosocial oncology in Kenya. Philip was elected in 2019 as a Director representing Africa in the International Psycho-Oncology Organization

Philip Odiyo is currently the Secretary for Prostate Cancer Support Association in Kenya and a board  member at Kenyan Network of Cancer Organizations; he is also a committee member representing developing countries at the International Society for Sexual Medicine (ISSM) and the Vice President of Association for Psycho-Oncology Society in Africa. 

Philip has presented in several IPOS meetings in Rotterdam (2013), Portugal (2014) and Berlin (2017). He has been actively involved in IPOS Academies in Durban (2013), Marrakech (2015) and Kigali (2016) and the 2019 Annual Fall Scientific meeting in Nashville, TN, USA. He was instrumental in the organization for the first ISSM/SMSNA Sexual Health conference in 2019 in Nairobi Kenya and the ongoing planning for the East African Virtual ISSM/SMSNA Virtual Sexual Health Symposium in December 2021.

He is a reviewer in the following Journals:  The Breast Journal, Supportive Care in Cancer, e-Cancer Journal and Psycho-Oncology: Journal of Psychological, Social and behavioural dimensions of cancer.